Kalytera Therapeutics
-
2014
Company Description
Kalytera Therapeutics is pioneering the development of a next generation of cannabinoid therapeutics.
Kalytera is pioneering the development of a next generation of cannabinoid therapeutics. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics.
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Company Website:
-
Company E-mail:
-
Company Address:
100 Cummings Center, Suite 412-GBeverly, MAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits